Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia

NCT06703489 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.

NCT NCT06703489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06703489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia
Lead sponsor
Medtronic Cardiac Ablation Solutions
Phase
Not applicable
Overall status
Recruiting
Start date
March 18, 2025
Completion date
May 31, 2027
Enrollment
60 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular tachycardia (vt)